Skip to main content
. 2016 Dec 27;8(4):6796–6808. doi: 10.18632/oncotarget.14296

Figure 7. AR-Q784* stabilizes AR-FL chromatin binding and enhances the recruitment of p300 coactivator.

Figure 7

A, B. ChIP-qPCR for measuring (A) AR-FL binding (using antibody against C-terminal region) or (B) p300 binding at an FKBP5 enhancer in LNCaP-AR-Q784* cells pretreated with vehicle or doxycycline and then stimulated by DHT (0, 0.1 or 1 nM) for 4h.